The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples. by Rodríguez-Rodríguez, L, Taib, W, Topless, R, Steer, S, González-Escribano, M, Balsa, A, Pascual-Salcedo, D, González-Gay, M, Raya, E, Fernandez-Gutierrez, B, González-Álvaro, I, Bottini, N, Witte, T, Viken, M, Coenen, M, van Riel, P, Franke, B, den Heijer, M, Radstake, T, Wordsworth, P, Lie, B, Merriman, T, Martín, J

The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in caucasian case-control samples. by Rodríguez-Rodríguez, L, Wan Taib, W, Topless, R, Steer, S, González-Escribano, M, Balsa, A, Pascual-Salcedo, D, González-Gay, M, Raya, E, Fernandez-Gutierrez, B, González-Álvaro, I, Bottini, N, Witte, T, Viken, M, Coenen, M, van Riel, P, Franke, B, den Heijer, M, Radstake, T, Wordsworth, P, Lie, B, Merriman, T, Martín, J

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update by Smolen, J, Landewé, R, Bijlsma, J, Burmester, G, Chatzidionysiou, K, Dougados, M, Nam, J, Ramiro, S, Voshaar, M, van Vollenhoven, R, Aletaha, D, Aringer, M, Boers, M, Buckley, C, Buttgereit, F, Bykerk, V, Cardiel, M, Combe, B, Cutolo, M, van Eijk-Hustings, Y, Emery, P, Finckh, A, Gabay, C, Gomez-Reino, J, Gossec, L, Gottenberg, J, Hazes, J, Huizinga, T, Jani, M, Karateev, D, Kouloumas, M, Kvien, T, Li, Z, Mariette, X, McInnes, I, Mysler, E, Nash, P, Pavelka, K, Poór, G, Richez, C, van Riel, P, Rubbert-Roth, A, Saag, K, da Silva, J, Stamm, T, Takeuchi, T, Westhovens, R, de Wit, M, van der Heijde, D